Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder.
Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder.
12/08/20, 8:05 AM
Location
toulouseMerieux Equity Partners (via OMX Europe Venture Fund), IRDI Soridec Gestion and M Capital Partners have joined a Series A financing round into Cell-Easy – a novel French pharmaceutical laboratory specialized in the development and manufacturing of novel cell therapies, for preclinical and clinical studies. This fund raising aims at accelerating the company’s growth in France and internationally, by expanding Cell-Easy management team and strengthening the company’s commercial presence in key regions.